Inspiremd to announce fourth quarter and full year 2024 financial results

Miami, feb. 26, 2025 (globe newswire) -- inspiremd, inc. (nasdaq: nspr), developer of the cguard™ prime carotid stent system for the treatment of carotid artery disease (cad) and prevention of stroke, today announced that it will release its fourth quarter and full year 2024 financial results on wednesday, march 12, 2025. in conjunction with the release, inspiremd will host a conference call and webcast at 8:30 a.m.
NSPR Ratings Summary
NSPR Quant Ranking